Treating patients with ALK-rearranged non-small-cell lung cancer: mechanisms of resistance and strategies to overcome it. [electronic resource]
Producer: 20180312Description: 658-666 p. digitalISSN:- 1699-3055
- Anaplastic Lymphoma Kinase
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Drug Resistance, Neoplasm -- physiology
- Gene Rearrangement
- Humans
- Lung Neoplasms -- drug therapy
- Protein Kinase Inhibitors -- therapeutic use
- Receptor Protein-Tyrosine Kinases -- genetics
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.